The largest database of trusted experimental protocols

5 protocols using anti cldn1

1

Immunohistochemical Staining of Key Regulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemical staining of LIN28B/CLDN1/NOTCH3 was performed following standard protocols. Briefly, paraffin-embedded tissue blocks were cut into 4 μm–thick sections. The tissue sections were incubated with anti-CLDN1 (catalog: 71-7800, Invitrogen; dilution 1:1,000), and anti-NOTCH3 (catalog ab23426, Abcam; 1:100) overnight at 4°C; incubated in Envision+ kits (Dako); and visualized using 0.01% 3,3′-diaminobenzidine. The staining intensities varied from 0 (negative), 1+ (weak), 2+ (moderate), to 3+ (strong). The percentage of cells at each staining intensity level was calculated, and H-score was assigned using the following formula; H-score = (1 × % cells 1+) + (2 × % cells 2+) + (3 × % cells 3+). High expression levels were designated as follows: LIN28B ≥ 120, CLDN1 ≥ 200, NOTCH3 ≥ 100. The score of immunohistochemical staining was evaluated independently by 2 investigators.
+ Open protocol
+ Expand
2

Monitoring Hepatitis C Virus Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-CD81 monoclonal antibody (mAb) 5A6 from Santa Cruz Biotechnology (Paso Robles, CA), anti-SRB1, anti-CLDN1, anti-OCLN antibodies, Alexa 488- and horseradish peroxidase (HRP) conjugated anti-goat or anti-rabbit or anti-mouse IgG from Invitrogen (Carlsbad, CA) were used in our study. Anti-NS3 and anti-core antibodies were purchased from Abcam (Toronto, Ontario, Canada).
+ Open protocol
+ Expand
3

Western Blotting Protocol for Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
All cells were lysed in 1% NP40 buffer (150 mM NaCl, 50 mM Tris-HCl pH 8, 10% glycerol, 2 mM EDTA) supplemented with 1 mM cOmplete Mini protease inhibitors (Roche) and 1 mM sodium orthovanadate (ThermoFisher). Proteins were separated on a 4–20% SDS-PAGE gel (BioRad) and transferred to polyvinylidene difluoride (PVDF) membrane. Membrane was incubated in 5% BSA and 0.1% Tween-20 in PBS for 1 hr, incubated overnight at 4°C with primary antibodies (1:10000 anti-β-actin, Santa Cruz #sc-47778; 1:1000 anti-SHC, BD Transduction #610878; 1:1000 anti-ERK, Invitrogen #13–6200; 1:1000 anti-phospho-SHC (Tyr239/240), Cell Signaling #2434; 1:2000 anti-phospho-p44/42 ERK (Thr202/Tyr204), Cell Signaling #4370; 1:1000 anti-EGFR, Cell Signaling #2232; 1:700 anti-phospho-Thr/Tyr, Cell Signaling #9381; 1:500 anti-CLDN1, Invitrogen #37–4900; 1:350 anti-OCLN, Invitrogen #33–1500), then incubated for 1 hr at room temperature with horseradish peroxidase-conjugated secondary antibodies (1:10000 anti-rabbit, Cell Signaling #7074; 1:10000 anti-mouse, Cell Signaling #7076). Membrane was added SuperSignal West Pico PLUS Chemiluminescent or West Femto Maximum Sensitivity substrate (ThermoFisher) and exposed to CL-XPosure film (ThermoFisher).
+ Open protocol
+ Expand
4

HIF1β and CLDN1 Expression in T84 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The NE-PER extraction kit was used to prepare nuclear lysates from confluent T84 monolayers per manufacturer's instructions (Thermo Scientific, Waltham, MA). Western blotting of these lysates was performed using HIF1β monoclonal mouse antibody (BD Biosciences, San Jose, CA) and TATA binding protein monoclonal mouse antibody (Abcam, Cambridge, United Kingdom). Western blotting on whole-cell lysates was done using rabbit polyclonal anti-CLDN1 (Invitrogen), polyclonal rabbit anti–β-actin (Abcam), and polyclonal antibodies against phosphorylated (Ser-19) and total myosin light chain (Cell Signaling Technology, Danvers, MA).
+ Open protocol
+ Expand
5

Immunoblotting Protein Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed with RIPA buffer supplemented with protease inhibitors (Roche Molecular Biochemicals; Indianapolis, IN, USA) and subjected to standard immunoblotting using anti-CD81 (1:1000; BD Biosciences, San Jose, CA, USA), anti-CLDN-1 (1:1000; Invitrogen), anti-SR-BI (1:1000; Abcam, Cambridge, UK), anti-OCLN (1:200; Cell Signaling Technology, Danvers, MA, USA), anti-Apolipoprotein B (ApoB, 1:5000; Abcam), anti-ApoE (1:5000; Calbiochem-Millipore, Billerica, MA, USA), and anti-β-actin (1:20000; Santa Cruz Biotechnology, Dallas, Texas, USA) primary antibodies, and anti-mouse (1:5000; Invitrogen) or anti-rabbit (1:2500; Sigma) secondary antibodies. Imaging was performed on an UVP chemiluminescence imaging system (UVP; Upland, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!